Abstract medical AI governance system connecting evidence, oversight, and assurance

Operational AI Governance™

Move AI governance from policy to proof.

SmartRisk helps regulated organizations identify AI, evaluate risk, direct remediation, validate controls, and maintain defensible evidence across the AI lifecycle.

Regulated-industry focus Evidence-based governance

Built for decisions where trust must be demonstrated

Medical DevicesPharma & BiotechHealth SystemsDigital Health

Two products. One governance journey.

Start focused. Scale with confidence.

SmartRisk 1 accelerates structured risk analysis. SmartRisk 2 provides the operating layer for enterprise AI governance, evidence, and assurance.

01
Focused risk analysis

SmartRisk 1

Guided FMEA workflows that reduce manual effort, improve consistency, and produce decision-ready risk documentation.

  • Structured FMEA workflow
  • Reusable risk logic
  • Clear document outputs
  • Faster cross-functional review
Explore SmartRisk 1
02
Design-partner program

SmartRisk 2

An executive governance instrument connecting AI inventory, risk, validation, remediation, evidence, and continuous monitoring.

  • Enterprise AI Registry™
  • Risk and classification engine
  • Governance remediation
  • Evidence-backed continuous assurance
Explore SmartRisk 2

From inventory to assurance

A continuous governance system—not another static checklist.

Every capability supports a decision, an accountable owner, and evidence that can withstand executive, customer, and regulatory scrutiny.

01

AI Registry™

Know every AI system, owner, intended use, status, and dependency.

02

Risk Engine™

Classify risk consistently and surface the decisions that require human judgment.

03

Evidence Vault™

Connect controls to traceable evidence instead of scattered documents and claims.

04

Continuous Monitoring™

See whether governance remains effective as systems, evidence, and obligations change.

See all eight capabilities

Purpose-built for regulated environments

Governance that understands the consequence of the decision.

Medical devices

Govern AI across product, quality, regulatory, and post-market workflows.

Pharma & biotech

Bring evidence, validation, and accountability into AI-enabled GxP decisions.

Hospitals & health systems

Create clear ownership and oversight for clinical and operational AI.

Digital health & AI vendors

Turn governance into buyer confidence and implementation readiness.

Consulting + platform

Assess what exists. Build what is missing. Operate what matters.

Engage SmartRisk for readiness assessments, medical AI governance, framework development, validation, remediation, implementation, executive workshops, or fractional governance leadership.

View consulting services
01AssessInventory, maturity, gaps
02ImplementControls, validation, remediation
03AssureEvidence, monitoring, leadership

Interactive decision tools

Turn interest into a practical next step.

Assess governance readiness or estimate the labor-capacity value of a more structured SmartRisk 1 workflow.

8 governance dimensions

AI governance readiness assessment

Receive a directional maturity score, identify the lowest-scoring dimensions, and download a concise result.

Take the assessment
SR1 business case

FMEA value calculator

Estimate baseline effort, annual hours redirected, and labor-capacity value using your own assumptions.

Calculate SR1 value
SmartRisk Field GuideMedical AI
Governance
From principles to operational proof

The forthcoming field guide

Medical AI governance, made operational.

A practical guide for leaders navigating AI risk, accountability, validation, regulatory expectations, evidence, and continuous assurance across the medical AI lifecycle.

Preview the book

Make AI governance defensible before it becomes urgent.

Begin with an executive conversation, a readiness assessment, or a focused SmartRisk pilot.

Request a conversation